Table 2.
Vehicle |
Ranitidine |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Day −3
|
Day −2
|
Day −1
|
Day −3
|
Day −2
|
Day −1
|
|||||||
Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | |
24-h water consumption, mL | 13.4* | 1.9 | 14 | 1 | 14.3 | 1 | 11.7* | 0.5 | 13.7 | 0.6 | 13.2 | 0.6 |
24-h Na+ excretion, µmol | 625 | 92 | 798 | 83.3 | 852 | 54.2 | 882 | 141.9 | 668 | 69.9 | 718 | 70.5 |
24-h Cl− excretion, µmol | 728* | 101.6 | 1,026 | 82.3 | 1,100 | 59.3 | 1,108* | 131.7 | 930 | 57.3 | 1,131 | 73.9 |
24-h K+ excretion, µmol | 1,498 | 549.1 | 1,375 | 350.4 | 1,515 | 352.4 | 1,634 | 409.3 | 1,231 | 221.8 | 1,294 | 86.1 |
8-h osmol excretion, mmol | 2.1 | 0.4 | 3.1 | 0.3 | 3 | 0.2 | 3.2 | 0.4 | 2.7 | 0.2 | 2.7 | 0.2 |
8-h urine pH, mmol | 5.3 | 0.1 | 5.3 | 0.1 | 5.4 | 0.04 | 5.4 | 0.04 | 5.8 | 0.4 | 5.9 | 0.4 |
n = 7 for vehicle treatment and 10 for ranitidine treatment. The following parameters were assessed: water consumption, urinary Na+ excretion, urinary Cl− excretion, and urinary K+ excretion for the 24-h period as well as 8-h osmol excretion and urine pH levels. *Statistical significance (P < 0.05) for vehicle vs. ranitidine treatment. Repeated-measures ANOVA with a Holm-Sidak post hoc test was used for statistical analysis.